Research Alliance Corporation III Class A Ordinary Shares RACC · News

website

Research Alliance Corporation III functions as a blank check company, also referred to as a Special ...

Price10.16

Market Cap92.44 M

Float6.4 M

CountryUS

SectorFinancial Services

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

FEATURED

Oak Hill Bio and Research Alliance Corporation III Announce Business Combination Agreement to Create Publicly Listed Rare Disease Biotechnology Company to Advance Antisense Oligonucleotide Therapy Rugonersen for Angelman Syndrome

Transaction to provide Oak Hill Bio with approximately $175 million in gross proceeds, including $75 million of cash in Research Alliance Corporation III’s (NASDAQ:RACC) ("RACC") trust account that is fully

Summary

Jul 27, 2026, 8:00 AM ·Globe Newswire

RECENT

RESEARCH ALLIANCE CORPORATION III ANNOUNCES PRICING OF $75 MILLION INITIAL PUBLIC OFFERING

NEW YORK, May 20, 2026 /PRNewswire/ -- Research Alliance Corporation III (the "Company"), a special purpose acquisition company, announced today the pricing of its initial public offering of 7,500,000 Class A

May 20, 2026, 9:00 AM ·PRNewswire